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Abstract
Background: The MANAS trial reported that a Lay Health Counsellor (LHC) led collaborative stepped care
intervention (the “MANAS intervention”) for Common Mental Disorders (CMD) was effective in public sector
primary care clinics but private sector General Practitioners (GPs) did as well with or without the additional
counsellor. This paper aims to describe the experiences of integrating the MANAS intervention in primary care.
Methods: Qualitative semi-structured interviews with key members (n = 119) of the primary health care teams
upon completion of the trial and additional interviews with control arm GPs upon completion of the outcome
analyses which revealed non-inferiority of this arm.
Results: Several components of the MANAS intervention were reported to have been critically important for
facilitating integration, notably: screening and the categorization of the severity of CMD; provision of psychosocial
treatments and adherence management; and the support of the visiting psychiatrist. Non-adherence was common,
often because symptoms had been controlled or because of doubt that health care interventions could address
one’s ‘life difficulties’. Interpersonal therapy was intended to be provided face to face by the LHC; however it could
not be delivered for most eligible patients due to the cost implications related to travel to the clinic and the time
lost from work. The LHCs had particular difficulty in working with patients with extreme social difficulties or alcohol
related problems, and elderly patients, as the intervention seemed unable to address their specific needs. The
control arm GPs adopted practices similar to the principles of the MANAS intervention; GPs routinely diagnosed
CMD and provided psychoeducation, advice on life style changes and problem solving, prescribed antidepressants,
and referred to specialists as appropriate.
Conclusion: The key factors which enhance the acceptability and integration of a LHC in primary care are training,
systematic steps to build trust, the passage of time, the observable impacts on patient outcomes, and supervision
by a visiting psychiatrist. Several practices by the control arm GPs approximated those of the LHC which may
partly explain our findings that they were as effective as the MANAS intervention arm GPs in enabling recovery.
Introduction
Mental health is central to the values and principles of
the Alma Ata Declaration, adopted by nations from
around the world at the landmark International Confer-
ence on Primary Health Care (1978). It is widely
acknowledged that integrating mental health care into
primary care is the only viable way of closing the treat-
ment gap for Common Mental Disorders (CMD) [1].
There are several reasons for this position, including the
large burden of mental disorders in primary health care
settings, the lack of specialist human resources and the
stigma associated with mental health care [1]. However,
currently the recognition and treatment of CMD among
the large number of people who attend primary care set-
tings with CMD is extremely inadequate [2] with a
* Correspondence: vikram.patel@lshtm.ac.uk
1Sangath, Alto-Porvorim, Goa 403521, India
Full list of author information is available at the end of the article
Pereira et al. International Journal of Mental Health Systems 2011, 5:26
http://www.ijmhs.com/content/5/1/26
© 2011 Pereira et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.consequent large unmet need for care [3]. Despite the
substantial evidence base on the efficacy of pharmacolo-
gical and psychosocial treatments delivered by non-spe-
cialist health workers in primary care settings [4,5],
efforts to integrate these into routine primary health
care have faced numerous challenges. One major chal-
lenge is the lack of human resources with the relevant
skills to deliver mental health care. Competing priorities
often lead to existing human resources being unavailable
or unmotivated to take responsibility for this task.
The MANAS intervention sought to overcome some
of these challenges through the use of trained lay coun-
sellors working in a collaborative care framework with
the primary care physician and a visiting mental health
specialist. The intervention was evaluated through a
cluster randomized controlled trial in public and private
primary health care settings. Altogether, 2796 patients
with a CMD from 24 primary health care clusters parti-
cipated with over 80% follow up rates at 2, 6 and 12
month, making this the largest trial in psychiatry from
the developing world [6]. The primary findings of the
trial revealed that the intervention led to significant
improvements in recovery rates from CMD in the public
sector clinics. There was no impact, however, in the pri-
vate sector where the ‘control’ arm General Practitioners
(GPs) were able to achieve outcomes comparable to
those in the Manas intervention arm [6]. We hypothe-
size that this could be due to the similarity of the ‘usual
care’ adopted by these GPs to the principles of the
MANAS intervention. This paper describes the experi-
ences of integrating the MANAS model into primary
care. It also explores the care provided by the control
arm GPs to ‘unpack’ the findings suggesting non-super-
iority of the collaborative care model in that sector.
Method
Setting
The MANAS trial was conducted in Goa, a state in west
India with a population of 1.4 million. It was implemen-
ted by Sangath, a Non Governmental Organization, in
collaboration with the London School of Hygiene and
Tropical Medicine, the Government of Goa’s Directorate
of Health Services, the Voluntary Health Association of
Goa and private general medical practitioners (GPs).
The MANAS trial was carried out in two consecutive
phases, first in 12 government run primary health care
facilities (Primary Health Centres or PHC’s) and then in
12 private GP practices. PHCs typically comprised an
average of 2-3 doctors and a team of non-medical work-
ers (nurses, community health workers, and administra-
tive staff). Their practice style is best described as a
‘collective clinic centred model’ where patients have lit-
tle privacy during consultations and may see different
doctors on different visits. All services, including
medications available in the PHC pharmacy, are free. In
contrast, GPs are single practitioner operated private
enterprises where all services are on a cash-basis and all
prescribed medications must be purchased. Their prac-
tices are small and have few ancillary staff beyond a
secretary. However, the patient typically will see the
same doctor on each visit and consultations take place
in a private room with a closed door; this model of care
has been referred to as an ‘individual, personalized cli-
ent-centred care model’[7].
Overview of Trial Design
The study was a cluster randomized trial conducted in
two consecutive phases, first with PHCs and then with
GPs, randomised to deliver either the MANAS Colla-
borative Stepped Care intervention or Enhanced Usual
Care control. Patients in all facilities were screened for
CMD by a trained lay person who was called the Health
assistant (HA) using the 12 item General Health Ques-
t i o n n a i r e( G H Q - 1 2 )w i t hac u t - o f fs c o r eo f5 / 6 ;t h e
results of the screening were provided to the primary
care physician. The MANAS intervention involved three
key members: the Lay Health Counsellor (LHC), the pri-
mary care physician and a visiting psychiatrist ("Clinical
Specialist”). Full details of the development and content
of the intervention have been previously published [8].
The LHC was a female college graduate, recruited from
the local community, who was trained to lead the inter-
vention in a structured two month course to deliver a
range of psychosocial treatments (psychoeducation,
interpersonal therapy, referral to appropriate agencies,
adherence support) for CMD. She acted as a case man-
ager for all patients who screened positive for CMD and
took overall responsibility for the intervention delivery,
working in close collaboration with the primary care
physician and the Clinical Specialist for all non-drug
treatments and supporting adherence with antidepres-
sants for those who were prescribed the drug by the pri-
mary care physician. In the control facilities, the results
of screening were providedt ot h ep h y s i c i a n sb yt h e
Health Assistant along with the treatment guidelines
manual; no other intervention was offered.
Interview participants and recruitment
All key members of the primary health care teams in the
MANAS intervention and control clinics (Primary Care
Doctors/GPs, Lay Health Counsellors, the Clinical Spe-
cialists and ancillary staff of the clinics) were invited to
participate upon completion of the trial. In addition, all
the six private practitioners in the control arm were
invited for an additional interview upon completion of
the outcome analyses of the MANAS trial which
revealed non-inferiority of this arm. Written informed
consent was a pre-requisite for participation.
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The interview guides for the semi- structured interviews
used in this study were developed, piloted and refined
to elicit information on the experiences of the respon-
dents during the trial. The first part of the guide cov-
ered the role of the respondent in intervention delivery
and his or her description of the role played by the
other key persons delivering the various components of
the intervention. The second part of the guide explored
experiences with each component of the intervention
and the respondent’s opinion on the program as a
whole. The control arm participants were only asked
about the screening component (i.e. detection of CMD)
as this was the only component added to the usual care
in those clinics. The secondary data collected from the
six GPs in the control arm sought to elicit information
about their practices in management of patients with
CMD with the goal of comparing these with the
MANAS intervention components.
All interviews were conducted by the first two authors
(GA, BP) who were not directly involved in the inter-
vention, within two months of completing the trial, in
their respective setting, maintaining privacy and confi-
dentiality. All interviews were audio-recorded. The
audio-recorded interviews were transcribed verbatim
and all local language interviews were translated into
English. All interviews were entered into AtlasTi (ver-
sion 4.2) software, and coded in an iterative manner
using a thematic framework of analyses. The data was
categorized into the following broad themes: the experi-
ences of integrating the intervention in the primary care
setup, the roles played by the various actors, challenges
faced, and the strategies used to overcome the chal-
lenges. The data for the six GP’si nt h ec o n t r o la r m
were coded in a similar manner and mainly focused on
how they managed patients with CMD before and dur-
ing the MANAS program and views about why they
achieved comparable results.
Ethical issues
All respondents were assured that participation was
voluntary and that no information identifying the indivi-
duals would appear in the reports. Written consent was
obtained from participants that included consent for
audio-recording. Approval was obtained from the IRBs
of Sangath and the LSHTM.
Results
A total of 119 subjects participated in this study (Table
1) of whom 48 were from the control arm clinics. Find-
ings are presented in two sections; the first addresses
the experiences of the integration of the MANAS pro-
gram in PHCs and GPs; the second addresses the prac-
tices of the control arm GPs.
Experiences of integration
Screening for CMD
The method for detection of CMD was through screening
with a validated questionnaire by a Health Assistant (HA),
recruited for this task. The benefits of the screening were
appreciated by most respondents who reported that
screening provided an opportunity for patients to talk
about their health and their problems. A key element for
the acceptability of the screening was the polite, coopera-
tive and friendly nature of the HA and that the screening
involved asking about personal concerns which were not
usually covered during health care consultations.
“She (HA) had a nice way with the patients. She made
them feel comfortable, she then inquired about their
health complaints. People liked that way.” [PHC clerk]
“Screening makes the patients feel better. Nobody asks
those questions, how you are feeling, how you are getting
along in life etc. It also makes the patients think because
such questions are never asked by anybody - it is for
them to look at whether they have got palpitations or
any other problem. Screening made all the patients to
think about their problem.” [PHC doctor]
While just over half the PHC doctors (12/20) and
most GPs (8/11) reported that they were diagnosing
CMDs prior to the program, almost all emphasized that
the screening and further categorization of CMD as
mild or moderate/severe and recording on a patient
card helped them in sharpening their diagnostic abilities
and providing treatment.
“The score card was very helpful in coming to the clear
cut diagnosis. Before the program we were not tapping
m u c ho fd e p r e s s e dc a s e sa n dw ew o u l dl a b e lt h e ma s
psychosomatic and most of the times give them vitamins
and tranquilizers, if severe cases then we would refer
them to the psychiatrist. Now we prescribe anti depres-
sants to these patients or send them for counseling.”
[PHC doctor]
“Screening helped me; it reinforced my ideas and
removed certain misconceptions from my mind like cer-
tain false cases that I would have treated for depression.”
[GP]
Several challenges to screening were reported, the most
common being the hesitance of patients to participate in
Table 1 Participants in MANAS qualitative study
Role in the MANAS program N
PHC doctors and GPs 31
Health Counsellor 17
Health Assistant (responsible for screening) 28
Clinical Specialist (visiting psychiatrist) 2
Ancillary Staff (Registration Clerk, Pharmacists, Staff Nurses, Auxiliary
Nurse Midwife, Extension Officer)
41
TOTAL 119
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they might miss their turn to see the doctor. To ease
these fears, the clinic staff provided information and reas-
sured patients about the benefits of the screening in
terms of its value for the overall medical assessment by
the doctor. Doctors also referred unscreened patients
without the patient card back for screening. Health Assis-
tants adopted a number of strategies, reassuring patients
that they would accompany them to the doctor in the
event that they missed their place in the queue.
“Patients are always in a hurry, most challenging was
to ask for their time from their busy schedule. They
would feel that they would miss the doctor so I had to
convince them. Patients never said that they will not give
time. All would depend on how the introduction is given
to the patient. Once patients are convinced then other
procedures are very easy.” [HA]
“In the beginning the patients used to ask why they are
calling us. We used to tell them that she (HA) would ask
you some questions on health and you have to answer
them. She (HA) has patience and would talk very nicely
with the patient.” [GP nurse]
Other challenges included engaging with patients who
had been non-cases during a previous screening encoun-
ter and who hesitated for re-screening; patients were re-
screened if they re-attended the practice only if there
was at least one month since the previous screening.
Some patients expected monetary benefits and some
patients influenced others not to go for screening. Some
HAs reported difficulties in handling too many patients
for screening and the rude behaviour of a few male
patients. These challenges were handled by providing
explanation about the benefits of the program, in parti-
cular its impact on the treatment the patient could
receive that day, and allocating an additional HA for
very busy clinics. The HA’s also attributed their skills to
the training on how to handle difficult situations and
the accompanying role plays. They observed that over
time when the doctors received positive feedback from
patients about the treatment t h e yg o tm o r ei n v o l v e di n
the program.
“Gradually doctors became aware of the program and
they began to take interest in the program like referring
unscreened patients. They also began to refer patients for
screening from the hospital ward, PHC sub-centers and
other people known to them. Patients would tell the doc-
tors that they had felt better, tablets had helped them.
B a s e do nt h ef e e d b a c ko ft h ep a t i e n t s ,d o c t o r ’sv i e w s
about the program changed and they cooperated.” [HA]
Medication practice by primary care doctors
The majority of the PHC doctors observed a change in
their prescription behaviour, notably reduced prescrip-
tion of benzodiazepines (15/20) and vitamins and tonics
(13/20) and increased prescription of antidepressants.
“Fluoxetine was not supplied by the DHS (Directorate
of Health Services) so I could not do anything. I had to
prescribe diazepam or B complex. When MANAS pro-
gram made it (Fluoxetine) available then we had an
upper hand to prescribe it to our patients.” [PHC doctor]
Similar changes were observed in GP prescription of
benzodiazepines, but most continued their practice of
prescribing vitamins and tonics.
“It is a tradition in my area even before I started my
practice. Psychologically patients feel that they should
have one bottle of tonic or some vitamins. Many a times
they ask doctor “we want one tonic bottle”. Sometimes
vitamins are really required especially anemic patients.”
[GP]
When doctors were asked about the experiences of
patients who received Anti-depressants (ADT), less than
half of the doctors pointed out that patients were com-
plaining of side effects like nausea, giddiness, dryness of
mouth and gastritis. The doctors handled side effects by
discontinuing ADT, switching to another ADT, or reas-
suring the patient to continue the medication in the
expectation that tolerance would develop. The majority
of doctors in both sectors expressed much greater confi-
dence in prescribing ADT to patients with CMD as a
result of the program.
“Now I am comfortable prescribing antidepressants to
patients because I have gained confidence in this drug.
There have been many patients, about seven to eight of
them who have been prescribed antidepressants. I felt
that so many patients have shown positive results, why I
can’t continue with the same medication.” [PHC doctor]
Psychosocial interventions delivered by the Lay Health
Counsellor
The role of the LHC was to be a case manager and pro-
vide psychoeducation to all patients with CMD, support
adherence for those receiving ADT, and provide inter-
personal therapy for patients with moderate/severe
depression or those who did not respond to ADT. Inter-
vention materials used by the LHCs included handouts
and a flip chart for psychoeducation. More than half of
the LHC’s reported that the patient card with the
screening results aided them in planning the interven-
tion for the patient. Almost all LHC’so b s e r v e dt h a t
handouts helped patients to remember the information
provided by them, and created awareness among the
family members as less literate patients were instructed
to get it read by their family members, thus facilitating
family support. The flip chart was observed to facilitate
the psychoeducation by helping the patients understand
the content better and acting as a guide to the LHC.
Most of the clinic staff mentioned that LHCs were
accepted by the patients as they were polite, friendly,
spent time building rapport with the patients and
respected confidentiality. However, the LHCs described
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the psychological treatments. During the early days of
the program, some LHCs reported difficulty remember-
ing the guidelines of psychoeducation, forgetting, for
example, to provide advice on some symptoms or
inquire about substance abuse. Some also experienced
difficulty in handling talkative patients, working with
patients with extreme social difficulties, counseling peo-
ple with alcohol related problems, and communicating
with elderly patients who found it difficult to follow the
instructions. Less common difficulties were resentment
by patients when the LHCs inquired about suicidal ideas
and, particularly in the GP sector, patients hesitating to
open up as they were known to the doctors and the
staff. Some patients requested financial assistance and
some refused treatment as they did not feel it would
help them.
“Some (patients faced) social difficulties like financial
problem which is mainly due to seasonal work, daily
wages, and alcoholism. Another problem was patients
not having proper documentation to apply for social
schemes e.g. unregistered marriage, so a woman cannot
apply for widow pension. So I found that there is no
proper channel to improve their social difficulties and
their problem remains same and this worsens their
health condition. But I tried to give them information
about various available schemes and how to follow the
procedure and some even applied for it.” [LHC]
T h em a j o r i t yo fL H C sr e p o r t e dt h a te x p e r i e n c ei n
the clinics, training before the program and monthly
peer group supervision during the program compris-
ing, for example, role plays of difficult scenarios, gave
them confidence to overcome the challenges they
faced. With experience, the LHCs adopted a flexible
approach of delivering psycho-education, improving
their skills in asking about suicidal ideas, and provid-
ing concrete information on welfare schemes and
referral agencies to address social difficulties and
reviewing progress on these issues in follow up
appointments. The LHCs observed that providing
explanations about the importance of treatment and
explaining the mind-body link also helped engage
patients who were skeptical about the program’s effec-
tiveness. LHCs also learnt to emphasize confidentiality
which helped patients become more comfortable in
talking to them.
“I stressed to every patient that whatever they would
confide in me would remain confidential. I felt these
words would make the patient feel more comfortable
with me and they would ventilate their feelings more
easily. Another aspect of psychoeducation which I felt
has helped a lot was the mind-body link which included
the patient explaining the stressors in their life which in
turn would affect their health.” [LHC]
LHCs delivered Interpersonal Therapy (IPT) face to
face in the primary care practice. However LHCs faced
great difficulties in delivering Interpersonal Therapy
(IPT) for two major reasons: first, because patients were
unable to attend the required minimum of 6 sessions,
and secondly because some patients were skeptical
about its potential benefits, preferring medication.
“Patients told that they won’tb ea b l et oc o m ef o rs o
many sessions. Some patients postponed the appoint-
ments and finally they dropped out. Some refused to con-
tinue saying they are better and don’t need to continue. I
felt that IPT is a good therapy but the response in my
PHC was poor. Whenever I introduced IPT to patients
most of them said that IPT will not help them to deal
with their problems; at least with medicines they will feel
better.” [LHC]
A few LHCs mentioned that as they gained experience
they incorporated some of the IPT components (giving
hope, interpersonal inventory, communication and deci-
sion analysis) into delivering psychoeducation and that
these components were helpful to handle interpersonal
problems. These informal actions of the PHC phase
were later formalized during the GP phase and extended
to all LHCs through a revision of the psychoeducation
procedure.
Many LHCs mentioned how the conviction of the pri-
mary care staff about the benefits of the program was a
critical element in enhancing patient engagement. They
reported some challenges with engaging the primary
care doctor, especially in the early days when some doc-
tors were not referring patients for counseling or playing
an active role in encouraging patients to accept the new
treatments. However, the involvement of the doctors
increased as they became aware of the positive feedback
about the treatment from patients. In addition, some
patients who had felt their health improve following
counseling also encouraged others to participate and
even created awareness in the community about the
program.
“Doctor was convincing patients to meet HC and take
benefits of the counseling and to regularly follow up. He
was also discussing with me about the treatment of the
patients.” [LHC]
Supervision by the Clinical Specialist
The role of the Clinical Specialist (CS), a visiting psy-
chiatrist, was to train the doctors in the intervention
clinics on the MANAS treatment protocols and use of
ADT and to support and supervise the primary care
teams in these clinics. Almost all the GPs, but fewer
PHC doctors (3/11), mentioned that the CS was suppor-
tive and that they had discussed a variety of clinical
issues with him, for example, diagnostic difficulties,
medication dosage and refractory patients. In the PHCs,
several doctors mentioned that they only sought
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would discuss the case with the CS and then report it to
the doctor. Almost all the doctors endorsed the impor-
tance of the role of the CS in the program.
“If I had any problem regarding patients, like if the
dose had to be increased or patient is having minor side
effects like giddiness or gastritis, I definitely consulted
him (CS) and asked as to what should be done. The reg-
ular follow ups that he made were very useful in know-
ing the progress of the program. He was always available
on the telephone whenever I had any difficulties. It is
definitely useful because a psychiatrist is always neces-
sary in running of such programs.” [PHC Doctor]
The LHCs also appreciated the CS’s support and gui-
dance in dealing with difficult cases, especially patients
with high suicide risk. They also mentioned that the CS
engagement with the clinic doctors, for example through
monthly performance reports to the doctors, played a
crucial role in engaging the doctors with the program.
The CS observed that there were variations in the
degree of enthusiasm and the personal interest by differ-
ent doctors in the program. CS was able to establish
continuing relationships with the GPs with whom train-
ing was an ongoing process whereas few PHC doctors
were available for supervision due to changing shifts or
doctors having other work commitments leading to
uneven engagement.
“There was reluctance to adopt stepped care treat-
ments in spite of repeated reminders during supervisory
visits. This was especially a problem with some older
doctors who have preconceived notions of depression and
found it hard to change them. Arranging for regular
supervision with all doctors in the clinic within time and
traveling constraints led to uneven support provided to
individual doctors.” [CS]
The CS was able to overcome some of these chal-
lenges through regular presentation of the program per-
formance to the practice staff, reviewing the program
protocol regularly with the doctors, and ensuring regular
visits to the clinics and availability on the phone. CS
pointed out that there were very few referrals and that
these were easily managed by them. CS mentioned that
building strategic relationships with key players within
the practice was crucial - being on time for meetings,
befriending staff in a respectful manner, being non judg-
mental, enthusiastic, responsive to the needs of the doc-
tors and practice staff, interacting in a non-demanding
and supportive manner with them, being persistent and
tenacious in sorting out problems, being patient and
understanding while encouraging the adoption of the
new requirements such as the use of a checklist and
changes in reporting format, and highlighting the posi-
tive impact of the interventi o no np a t i e n t si m p r o v e d
acceptance of the program.
“The general acceptance of each doctor of the program
and their readiness to receive feedback/inputs was of
great help. Also, the HC’s integrating themselves in the
clinic led to greater acceptance of the program. Our
availability at all times over the phone was also benefi-
cial.” [CS]
Patient adherence
MANAS faced a number of challenges in achieving
patients adherence to the program for a variety of rea-
sons; the team generated a range of strategies to over-
come these challenges as summarized in Table 2.
These included a variety of strategies used by LHCs,
sometimes with mixed responses.
“I used to emphasize taking medicines (antidepres-
sants) for at least six months and gave flexible follow-up
appointment according to patient’sc o n v e n i e n c e .Ia m
always in my cabin during the appointment timings as
some patients were on time ...I remind patients who miss
their appointments with phone calls, letters or contacting
through PHC field health workers. It is natural that
patients can forget their appointment when they are
stressed or depressed.” [LHC]
“Many times I am faced with the problem where
patients do not like us to send letter to remind them of
appointments or phone them. In one instance one
patient came and told me “you stop sending letters to
m e ,p e o p l ea r es u s p i c i o u sw h yl e t t e r sa r ec o m i n gt om e
from the clinic. I will continue my medicines”.S oI
stopped but that patient was regular in taking medi-
cine. But there was another patient just opposite; she
would come to the clinic only when she receives the
reminder letter.” [LHC]
Some doctors reported that some patients complained
that there was no improvement with medication, that
the treatment was for long duration, or that they didn’t
come back if they felt better; some patients also felt that
there were no health care answers for life stressors.
“When patients feel little better they do not come for
treatment. After two months again when the symptoms
comes back, they come back again to us. [Doctor]
“These patients are living through stress and they con-
sider stress as accepted part of life and they feel that
what doctor will do about it.” [PHC doctor]
The doctors also provided support for adherence man-
agement through information about the treatments and
instructing patients to report any discomfort. Longer
prescriptions, for example for one month (in PHCs, pre-
scriptions were usually for two weeks duration) were
also provided for patients who lived a long distance
away. Some GPs did not charge fees for follow-up visits,
provided free medicines to a few patients with financial
difficulties and prescribed cheaper ADT brands. The
LHCs kept up to date lists of available ADT brands in
their local pharmacy and their costs to the doctor.
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In the following sections we describe the practices of
the GPs in the control arm, in comparison to those car-
ried out in the MANAS collaborative stepped care
approach.
Psychosocial interventions
All 6 control arm GPs routinely diagnosed CMD by tak-
ing a history which covered both the patient’s health
and personal and family problems; three explicitly
inquired about suicidal behaviours, providing counseling
and informing family members. All but one explained
the diagnosis to their patients as having a “psychological
problem“. The other GP previously referred to CMD as
a “mental illness“, but switched to using the term “men-
tal stress“ during the program.
“Those individuals who used to present us with various
vague complaints, we used to explain to these types of
patients that they don’t have any disease and their
symptoms are mainly psychological, so you try and take
some antidepressants or some anti anxiety tablets, it will
help you.”
“I would tell them that you don’t have any illness and
your illness is only of thinking about your family or your
home”
All the GPs provided psychosocial guidance for perso-
nal or family problems, for example some GPs provided
advice on lifestyle change, others gave advice on how
patients should distract themselves from their problems
and/or share with relatives. They also provided them
information on yoga or referral agencies such as Alco-
holic Anonymous. Two GPs taught patients problem
solving techniques.
“If some patients have family problems then I used to
call their relatives or their closest person and explain to
them. I also give advice, for example change in the life
style, change in the environment in the house whenever
it was the cause.”
“I used to tell them even earlier also pin point your
problems; write down your problems. Once you identify
your problems half of it is solved.”
Medication practice
Prior to the program, four of the 6 GPs routinely pre-
scribed ADT and also gave information about the side
effects; the other two GPs who usually prescribed ben-
zodiazepines modified their medication practice to ADT
during the program. Half the GPs mentioned that they
also prescribed vitamins, and benzodiazepines concur-
rently with ADT. Half the GPs reported that they would
prescribe ADT to patients with mild CMD before the
program, but changed to offering counselling for these
patients during the program. All the GPs would discon-
tinue the treatment after symptom recovery.
“Once they come back and I know that their problem is
getting solved, they are feeling better I start reducing the
dose and then gradually I stop the treatment.”
Specialist referral
Most GPs (4/6) referred patients with severe CMD to a
Psychiatrist.
Adherence management
Most GPs informed and convinced the patients to con-
tinue treatment for longer duration and gave the follow
up appointment after every 15 days.
“I tell them (patients) that unless you take these medi-
cines you won’t come out of it and to come out of it you
Table 2 Adherence barriers and strategies adopted
Barriers to adherence Strategies
Inability to send reminders: due to wrong address or wrong
phone number; no phone number; not giving consent to send
reminder letter.
*Reminders through a variety of modes tailored to each patient, for
example: contact through community health workers, phone number
of relatives or neighbors.
Cost: Medicines, Doctor’s fee (GP practices), and travel for
sessions.
Addressing financial difficulties, for example providing information
about widow pension or senior citizen welfare schemes.
Reducing costs, by prescribing cheaper ADT brands, providing free
medication to patients with financial difficulties, long duration
prescriptions.
Unable to come to the clinic: due to living long distance from
clinic; child care responsibilities; unable to get time off work.
Flexible appointments according to the convenience of the patient.
Reducing patient waiting time: registering in advance for doctor’s
appointment to avoid waiting in queue.
Age: Elderly patients forget appointment and also need company
to come to clinic.
Phone Counseling.
Seeking family support for example, to collect medication after the
phone session with the patient.
Treatment related: “felt better” and thus discontinued treatment;
side effects of medicine; no improvement with medication; long
duration of treatment; no health care answers for life stressors.
Addressing treatment concerns for example, joint consultation on
side effects with the doctor.
Lack of engagement of treating doctor and/or clinic staff. *Regular feedback to doctor and primary care team about program
performance.
Unavailability of ADT in local pharmacy. Checking and promoting the availability of ADT in local pharmacy.
Note: * Strategies used in all cases
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It is not like other medicines for cold and fever where
you take the medicines for few days and you are alright.
I will give you these medicines, review you and depend-
ing on your condition I will increase or reduce the dose.”
One GP provided a health record booklet to patients
which they needed to bring for every follow up visit,
sent birthday greeting cards to patients, and involved
family members in adherence management.
At the end of the interview when GPs were informed
about the trial finding that patients who were receiving
care in their clinic did as well as those who were receiv-
ing care in the clinic with a LHC, they explained this
finding as being due to patients having “faith“ in them
and the rapport developed with their patients over many
years they had been running their practice. They were
aware of the patients’ family backgrounds, took time to
listen to their problems, took detailed information about
their problems, and offered treatment and advice
accordingly.
“I think it was because we have good rapport with the
patients, they can talk to us better, sometimes before
they come to me I know their problems, since childhood I
know them and also their families“
“I feel that we go into the details of the problems of the
people, we talk to them, we come to know their problems
and help them. All this helps the patients”.
Discussion
The integration of mental health in primary care is one
of the most widely established axioms in global mental
health; yet, there are few descriptions of the challenges
and opportunities in the context of actual interventions
aiming to achieve integration. The MANAS trial is the
largest evaluation of such an intervention in a develop-
ing country. This paper describes the findings of semi
structured interviews carried out on completion of the
trial, with all the key health care stakeholders involved
in both intervention and control arms, in order to
explore their experiences of the program. Key innova-
tions of MANAS were its method of case identification
by routine screening, the utilisation of a trained Lay
Health Counsellor (LHC) as a case manager in the
clinics, and the provision of a visiting psychiatrist (the
Clinical Specialist) to support the primary care team.
Our main findings are that the primary care doctors
found the program to be a valuable addition to primary
care, and their acceptance of this program evolved over
time as their rapport with and trust of the LHC’sc o m -
petence grew and they observed benefits to patient clini-
cal outcomes. Several components of the intervention
were specifically reported to have been valuable: screen-
ing and the categorization of the severity of CMD and
reporting of the results on a patient card was an aid to
the doctor in diagnosis and providing treatment by
overcoming the challenges of the shortage of time and
the common presentation of somatic symptoms; the
LHC provided a range of psychosocial treatments and
emphasized adherence management which widened the
scope of health care interventions and enhanced the
likelihood of success; and the Clinical Specialist sup-
ported the team and gave confidence to the doctor to
support the program in the clinic, prescribe anti-depres-
sant medication and reduce the use of benzodiazepines
and nutritional supplements. The new members of the
team (the LHC and Clinical Specialist) also reported
that their efforts to integrate the program had greater
impact with the passage of time and the observed bene-
fits to patients. Systematic preparation in the form of a
comprehensive training program focusing on skills
based learning, followed by a structured on-the-job
supervision protocol comprising both on-site supervi-
sion by the Clinical Specialist and once a month peer-
group supervision with other LHCs were cited as criti-
cally important elements for successful delivery of the
program.
Several challenges were also observed, some of which
were resolved during the program but others were not.
The hesitance of patients to engage with the interven-
tion reduced in time as the procedures related to the
intervention became routine and the clinic staff pro-
vided information and reassured patients about the ben-
efits of screening and that they would not miss their
place in the queue. Non-adherence was common and
was attributed to a number of reasons, often because of
the feeling that continuing treatment was not needed as
symptoms had been controlled or because of doubt that
health care interventions could address one’s ‘life diffi-
culties’. Interpersonal therapy, provided face to face in
the facility, required several visits for hour-long sessions,
could not be delivered as planned due to the cost impli-
cations related to travel to the clinic and the time lost
from work. Cost factors were also a barrier to medica-
tion adherence in the GP practices. The LHCs had par-
ticular difficulty in working with patients with extreme
social difficulties or alcohol related problems, and
elderly patients, as the intervention seemed unable to
address their specific needs. Some patients dropped out
of the intervention because they felt there was no
impact on their health or because they were dissatisfied
with the length of time taken to help them recover.
However, in time the LHCs were accepted by the
patients and appreciated by the primary care staff due
to their polite and friendly nature and also for maintain-
ing confidentiality. Regular contact by intervention team
members with the health facility staff, for example
through regular feedback of the progress of the pro-
gram, helped engage with and enhance the support of
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tegies they had adopted to improve adherence, tailoring
these to address the barriers expressed by specific
patients.
Our interviews with the control arm GPs revealed a
number of practices which approximated the program
interventions to the extent to which these might well
explain their comparable performance. Most GPs routi-
n e l yd i a g n o s e dC M Da n dp r o v i d e dp s y c h o e d u c a t i o n ,
advice on life style changes and problem solving. Most
GPs routinely prescribed ADT and referred patients
with severe CMD to a psychiatrist. Above all, GPs devel-
oped good rapport with patients, offering one-to-one
consultations in a private space, maintaining confidenti-
ality, and offering advice which reflected their long-
standing relationship with the patient and understanding
of the patient’s social context.
In conclusion, our research shows that a trained lay
health counsellor is an acceptable addition to the pri-
mary health care team for the provision of mental health
care and that adequate training, systematic steps to
build rapport and trust, the passage of time, the obser-
vable impacts on patient outcomes, and the support and
supervision by a visiting specialist are key elements to
enhance the integration of the mental health care inter-
v e n t i o n .T h ep r i m a r yr o l eo ft h ec o u n s e l l o ri st ob ea
case manager, coordinating continuing care and provid-
ing all psychosocial interventions. In the context of the
private GPs who participated in the MANAS trial, most
of the roles played by the LHC were already being per-
formed by the GP, and thus the control arm GPs were
as effective as those with a LHC in enabling recovery. In
these practices, the provision of screening for case-
detection is a sufficient intervention to achieve compar-
able outcomes. The effective integration of mental
health in primary care, therefore, relies most crucially
on a systematic process for the detection of CMD fol-
lowed by a therapeutic relationship with a primary care
provider which addresses the symptoms of CMD
through an appropriate combination of psychosocial
interventions, antidepressant medication and referral to
specialist mental health providers. Future research
should focus on the development and evaluation of spe-
cific, structured, psychological treatments which address
the barriers we experienced with delivering interpersonal
therapy, and examine whether the addition of this treat-
ment enhances the effectiveness of the LHC intervention
package.
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